Quadrant Biosciences Inc.
Translating science into innovative diagnostic solutions
Quadrant Biosciences Inc. is a life science company involved in the development of functional assessments and epigenetic diagnostic solutions for large-scale health issues. Quadrant Biosciences has also entered into collaborative research relationships with a number of institutions including SUNY Upstate Medical University and Penn State University to explore and develop novel biomarker technologies with a focus on Autism Spectrum Disorder, concussion, and Parkinson's Disease.
Our product, Clarifi ASD, a saliva test available through pediatricians and family practitioners, aims to reduce the time it takes to be diagnosed with autism by providing a non-invasive, accurate test that aids in the early diagnosis of autism spectrum disorder in children ages 18 months through six years. Results are available within 3-6 weeks and easily administered in-clinic. For more information on the research behind early autism diagnosis and the Clarifi test, visit ClarifiASD.com.
Brands: Clarifi ASD, aims to reduce time to diagnosis by providing a non-invasive, accurate test that aids in the early diagnosis of autism spectrum disorder in children ages 18 months through 6 yrs.